AllergEase Inc — Form D/A
AllergEase Inc of DANVILLE, VA, a company, filed a Form D amendment with the SEC on 2014-04-03. The offering totals $1.5M, of which $1.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2014-04-03
- Form: D/A
- Accession: 0001214659-14-002588
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $1.5M
- Amount sold: $1.1M
- Remaining: $419K
- Minimum investment: $13K
- Investors: 42
- Date of first sale: 2013-02-04
- Security types: debt
- Revenue range: $1,000,001 - $5,000,000
- SEC file number: 021-192012
Issuer
- Name: AllergEase Inc
- CIK: 0001569902
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 541 BRIDGE STREET, DANVILLE, VA, 24541-1405
- Phone: 703-926-7215
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Dan Nelson Engel | Director | Indianapolis, IN |
| Luke Nelson Fry | Director | Santa Monica, CA |
| Omar Javery | Director | Boston, MA |
| Zeeshan Kaba | Director | Danville, VA |
| Xandra Nelson Laskowski | Director | Newport Coast, CA |
| Nancy Lai Sum Wong | Director | Newport Coast, CA |
| Sam Nelson Yousefzadeh | Director | Fairfax, VA |
| Omar Javery | Executive Officer | Boston, MA |
| Zeeshan Kaba | Executive Officer | Danville, VA |
| Nancy Lai Sum Wong | Executive Officer | Newport Coast, CA |
| William Nelson Pascarella | Director | Chantilly, VA |
| Nancy Nelson Wong | Executive Officer | Newport Coast, CA |
Other filings by this issuer (1)
More